The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Augmentation of Behavior Therapy With d -Cycloserine for Obsessive-Compulsive Disorder
Abstract
OBJECTIVE: This study examined whether d-cycloserine, a partial agonist at the N-methyl-D-aspartate (NMDA) glutamatergic receptor, enhances the efficacy of behavior therapy for obsessive-compulsive disorder (OCD). METHOD: A randomized, double-blind, placebo-controlled trial investigating D-cycloserine versus placebo augmentation of behavior therapy was conducted in 23 OCD patients. Patients first underwent a diagnostic interview and pretreatment evaluation, followed by a psychoeducational/treatment planning session. Then they received 10 behavior therapy sessions. Treatment sessions were conducted twice per week. One hour before each of the behavior therapy sessions, the participants received either D-cycloserine, 100 mg, or a placebo. RESULTS: Relative to the placebo group, the D-cycloserine group's OCD symptoms were significantly more improved at mid-treatment, and the D-cycloserine group's depressive symptoms were significantly more improved at posttreatment. CONCLUSIONS: These data provide support for the use of D-cycloserine as an augmentation of behavior therapy for OCD and extend findings in animals and other human disorders suggesting that behavior therapy acts by way of long-term potentiation of glutamatergic pathways and that the effects of behavior therapy are potentiated by an NMDA agonist.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“research demonstrated that, relative to those given a placebo pill, patients taking d-cycloserine before engaging in exposure therapy experienced a faster rate of symptom improvement in the first few weeks of receiving ERP.[57]”
From Exposure and response prevention for obsessive-compulsive disorder: A review and new directions (2019) · cites this paper as [57]
In the citing paper
“The findings of the present study suggest that the weak or null effects observed in these previous studies may be accounted for by large individual variability in fear extinction observed in therapy sessions.”
From D-cycloserine enhancement of fear extinction is specific to successful exposure sessions: evidence from the treatment of height phobia (2013) · cites this paper as [14]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders.
Widiger, T. A. (2000) · Oxford University Press eBooks · doi:10.1037/10518-009 · Cited by 19,766
The Yale-Brown Obsessive Compulsive Scale: I. Development, Use, and Reliability
Goodman, W. K. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110048007 · Cited by 7,712
Structured Clinical Interview for DSM-IV Axis I Disorders
Spitzer, R. L., First, M. B., & Gibbon, M. (1997) · Medical Entomology and Zoology · Cited by 3,582
Fear conditioning induces associative long-term potentiation in the amygdala
Rogan, M. T., Stäubli, U. V., & LeDoux, J. E. (1997) · Nature · doi:10.1038/37601 · Cited by 1,310
Ressler, K. J., Rothbaum, B. O., Tannenbaum, L., Anderson, P., Graap, K., Zimand, E., Hodges, L., & Davis, M. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.11.1136 · Cited by 1,063
Foa, E. B., Liebowitz, M. R., Kozak, M. J., Davies, S., Campeas, R., Franklin, M. E., Huppert, J. D., Kjernisted, K., Rowan, V., Schmidt, A. B., et al. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.1.151 · Cited by 1,048
Why We Think Plasticity Underlying Pavlovian Fear Conditioning Occurs in the Basolateral Amygdala
Fanselow, M. S., & LeDoux, J. E. (1999) · Neuron · doi:10.1016/s0896-6273(00)80775-8 · Cited by 933
Walker, D. L., Ressler, K. J., Lu, K.-T., & Davis, M. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-06-02343.2002 · Cited by 815
Augmentation of Exposure Therapy With D-Cycloserine for Social Anxiety Disorder
Hofmann, S. G., Meuret, A. E., Smits, J. A. J., Simon, N. M., Pollack, M. H., Eisenmenger, K., Shiekh, M., & Otto, M. W. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.3.298 · Cited by 560 · cited 4×
“on social anxiety (14), in our OCD study, the medication was given 1 hour before each session.”
BackgroundMethodInfluentialWhittal, M. L., Thordarson, D. S., & McLean, P. D. (2005) · Behaviour Research and Therapy · doi:10.1016/j.brat.2004.11.012 · Cited by 417
Research works printed but not linked: 4
- Cox J, 1994, Q J Exp Psychol B, 47, 187
- Kozak MJ, 1997, Tex
- First MB, 1995, Patient Edition (SCIDP, version 2.0).
- Beck AT, 1996, Steer RA
Cited by
Sorted by citations
Items 301–358 of 358
Augmentation of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder
Goddard, A. W., & Shin, Y. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511973796.005 · Cited by 1
Berger, S. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61530-5 · Cited by 1
D-Cycloserine Augmentation of Cognitive-Behavioral Therapy for the Treatment of Anxiety Disorders
Janicak, P. G., Dattilo, N. C., Manos, R. C., Storch, E. A., & Goddard, A. W. (2011) · Psychopharm Review · doi:10.1097/01.psyphr.0000399653.06660.fa · Cited by 1
Evaluating Strategies for Combining Pharmacotherapy with Cognitive Behavioral Therapy
Charney, M. E., Calkins, A. W., Hallion, L. S., & Simon, N. M. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2605-3_21 · Cited by 1
D-cycloserine en exposure in de behandeling van posttraumatische stressstoornis1
de Kleine, R. A., & van Minnen, A. (2012) · GZ - Psychologie · doi:10.1007/s41480-012-0059-2 · Cited by 1
Schmahl, C. G. (2009) · Springer eBooks · doi:10.1007/978-3-540-88489-7_4 · Cited by 1
Understanding Human Fear Extinction: Insights from Psychophysiology
Woodford, J., Riser, M., & Norrholm, S. D. (2023) · Current topics in behavioral neurosciences · doi:10.1007/7854_2023_435 · Cited by 1
The Use of Glutamate Modulating Drugs in Obsessive Compulsive Disorder
MacMaster, F. P., & Rosenberg, D. R. (2010) · Child and Adolescent Psychopharmacology News · doi:10.1521/capn.2010.15.6.1 · Cited by 2
Antidepressant use with d-Cycloserine may block fear extinction
Fang, A., & Wilhelm, S. (2016) · Evidence-Based Mental Health · doi:10.1136/eb-2015-102177 · Cited by 1
Self-citationTranslating Across Circuits and Genetics Toward Progress in Fear- and Anxiety-Related Disorders
Ressler, K. J. (2021) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.19205 · Cited by 1
Kapfhammer, H. (2011) · Springer eBooks · doi:10.1007/978-3-642-03637-8_58 · Cited by 1
Relationship Between Oxidative Stress and Obsessive–compulsive Disorder
Rabe‐Jabłońska, J., & Dietrich‐Muszalska, A. (2014) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-1-4939-0440-2_6 · Cited by 1
Obsessive‐Compulsive Disorder: Assessment and Treatment
Amitai Abramovitch, A., Elliott, C. M., Wilhelm, S., Steketee, G. S., & Wilson, A. C. (2014) · Wiley eBooks · doi:10.1002/9781118775349.ch51 · Cited by 1
Self-citationBiological Models and Treatments for OCD in Adults
Stewart, S. E., & Loh, A. S. (2017) · Wiley eBooks · doi:10.1002/9781118890233.ch14 · Cited by 1
Guastella, A. J., & Alvares, G. A. (2012) · Wiley eBooks · doi:10.1002/9781119945901.ch5 · Cited by 1
de Leeuw, A. S. (2013) · Utrecht University Repository (Utrecht University)
Atypical Psychopharmacologic Strategies
Shatkin, J. P., & Janssen, A. C. (2012) · Wiley eBooks · doi:10.1002/9781119958338.ch15
Childhood anxiety disorders: best treatment options and practice
Vidair, H. B., & Rynn, M. A. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511777578.029
Thérapies comportementales et cognitives
Pélissolo, A., & Montefiore, D. (2009) · Elsevier eBooks · doi:10.1016/b978-2-294-70563-2.00003-x
Pies, R. W. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08040502
Understanding the causes of anxiety
Simpson, H. B., Neria, Y., Lewis‐Fernández, R., & Schneier, F. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511777578.015
Aupperle, R. L. (2009) · KU ScholarWorks (The University of Kansas)
Cognitive-Behavioral Therapy for Obsessive-Compulsive Disorder
Sassano-Higgins, S. A., Sapp, F., & Noppen, B. L. V. (2015) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.130207 · Cited by 1
[Therapeutic strategies for obsessive-compulsive disorder refractory to treatment].
Mussa, A. (2008) · PubMed
cortexcircuits for fear and addiction overlap in prefrontal
Peters, J., Kalivas, P. W., & Quirk, G. J. (2009)
Translational approaches to the treatment of anxiety disorders
Gillespie, C. F., Weiss, T., & Ressler, K. J. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511980053.003
Voderholzer, U., & Hohagen, F. (2009) · Elsevier eBooks · doi:10.1016/b978-3-437-24900-6.50016-2
Treatment of Obsessive- Compulsive and Related
Stein, D. J. (2014)
20 jaar Neuropraxis: nieuwe ontwikkelingen in ‘dwang en hersenen’
Olivier, B. (2017) · Neuropraxis · doi:10.1007/s12474-017-0151-x
Muse, M. D., & Stahl, S. M. (2017) · Wiley eBooks · doi:10.1002/9781119152606.ch6 · Cited by 1
Innovative pharmakologische Strategien gegen Angststörungen
Kiebs, M., & Hurlemann, R. (2018) · NeuroTransmitter · doi:10.1007/s15016-018-6296-x
D-Cycloserine: A Novel Antidepressant to Be Explored?
Brainch, N., Virani, S., & Bazzi, L. (2018) · Psychiatric Annals · doi:10.3928/00485713-20180308-01
A system for the visual detection and analysis of obsessive compulsive disorder
Cameron, C. (2018) · RMIT Research Repository (RMIT University Library) · doi:10.25439/rmt.27588936
Stovezky, Y. R., Gershkovich, M., Kayser, R. R., & Simpson, H. B. (2018) · Cambridge University Press eBooks · doi:10.1017/9781108164313.020
Anderson, R. J., Groundwater, P. W., Todd, A., & Worsley, A. J. (2012) · doi:10.1002/9781118325421.ch14
Burns, W. J., Rey, J., & Burns, K. A. (2009) · Springer eBooks · doi:10.1007/978-0-387-09757-2_40
Sudak, D. M. (2011) · Wiley eBooks · doi:10.1002/9781118093368.refs
Schmahl, C. G. (2013) · Springer eBooks · doi:10.1007/978-3-642-35068-9_4
Schmahl, C. G. (2019) · Springer eBooks · doi:10.1007/978-3-662-58470-5_6
Rosenberg, D. R., Easter, P. C., & Michalopoulou, G. (2012) · Wiley eBooks · doi:10.1002/9781119941125.ch10
Veale, D. M., & Neziroglu, F. (2010) · Wiley eBooks · doi:10.1002/9780470684610.refs
Schmahl, C. G. (2022) · Springer eBooks · doi:10.1007/978-3-662-64057-9_6
Johnson, P. D. R. (2010) · CRC Press eBooks · doi:10.1201/b13787-137
Treatment of Psychiatric Comorbidities in Tourette Syndrome
Cardona, F., & Rizzo, R. (2022) · Oxford University Press eBooks · doi:10.1093/med/9780197543214.003.0027
Exposure therapy based on an inhibitory learning approach: A systematic review
Sato, T., Tanaka, T., & Maeda, S. (2023) · The Japanese journal of psychology · doi:10.4992/jjpsy.94.21405
Chapter 52. Treatment of Obsessive-Compulsive Disorder
Kayser, R. R., & Simpson, H. B. (2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375523.as52 · Cited by 1
Chapter 17. Pharmacotherapy for OCD
Grancini, B. M., Craig, K. J., Cinosi, E., Shodunke, A., Reid, J. E., Marinova, Z., & Fineberg, N. A. (2020) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615379378.lg17
Chapter 9. Emerging and Alternative Therapies
Roy, M. J., Rizzo, A., Difede, J., & ROTHBAUM, B. O. (2010) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615376667.lg09
Innovative treatment approaches for paediatric obsessive-compulsive disorder
Marazziti, D., Gurrieri, R., Gambini, M., Russomanno, G., Palagini, L., & Mucci, F. (2025) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2025.2591073
Treatment of anxiety: current status and controversial issues
Simpson, H. B., Neria, Y., Lewis‐Fernández, R., & Schneier, F. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511777578.024
Bation, R. (2018) · theses.fr (ABES) · doi:10.70675/3c89240bzc242z45f4z9247z73969c8af558 · Cited by 1
Hudak, R., Eken, H. N., & Donahue, C. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-27446-6.00006-6
Eghdami, S., Boroon, M., Keshavarz‐Akhlaghi, A., & Shalbafan, M. (2026) · Psychopharmacology · doi:10.1007/s00213-026-07155-z
Metadata
- Authors
- Wilhelm, S., Buhlmann, U., Tolin, D. F., Meunier, S. A., Pearlson, G. D., Reese, H. E., Cannistraro, P., Jenike, M. A., & Rauch, S. L.
- Affiliations
- Harvard University (US)
- ORCID
- Venue
- American Journal of Psychiatry
- Published
- 2008-03
- Volume
- 165
- Issue
- 3
- Pages
- 335-341
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2038335379
- Semantic Scholar
- d1309dc52689e30eae911778d6e9c8b6cc61a87f
- Cited by
- 358
- References
- 30
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 3 · 2023: 5 · 2022: 4 · 2021: 5 · 2020: 7 · 2019: 11 · 2018: 16 · 2017: 24 · 2016: 13 · 2015: 24 · 2014: 36 · 2013: 33 · 2012: 41
- FWCI
- 48.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Social Sciences › Psychology › Clinical Psychology › Psychoanalysis and Psychopathology Research
- Keywords
- D-cycloserine, obsessive-compulsive disorder, behavior therapy, augmentation therapy, NMDA receptor partial agonist, glutamatergic pathways, long-term potentiation, depressive symptoms
- MeSH terms
- Adult, Animals, Behavior Therapy, Combined Modality Therapy, Cycloserine, Double-Blind Method, Female, Follow-Up Studies, Humans, Implosive Therapy, Obsessive-Compulsive Disorder, Placebos, Psychiatric Status Rating Scales, Severity of Illness Index, Receptors, N-Methyl-D-Aspartate, Treatment Outcome, Diagnostic and Statistical Manual of Mental Disorders, Rats, Secondary Prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
